CORZTechnology · Software - InfrastructureThe 17 Wall Street analysts covering Core Scientific, Inc. hold a median 12-month price target of $36 — +99.0% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 18 of 100 as at 8 Sept 2026 — in the weakest quartile. The Street sees upside; the factor read is a caution. That gap is the story on this page.
Consensus tells you what everyone already believes. The model scores Core Scientific, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.
Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested
Momentum (75): The shares have been drifting up relative to others.
Accruals (10): A large share of reported profit has not shown up as cash, or the balance sheet is expanding quickly — both tend to unwind.
Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.
The bullish and bearish analyst opinions on CORZ, reported as data — targets and ratings, the market's view beside the model's.
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Data provided by Twelve Data
The green dot is the last close — the median target sits +99.0% from it.
Of the 20 most recent actions, 6 moved their price target up and 0 moved it down.
| Date | Firm | Action | Rating | Target |
|---|---|---|---|---|
| 3 Aug 2026 | B. Riley Securities | Maintains | Buy | $33 → $42 |
| 30 July 2026 | Keefe, Bruyette & Woods | Upgrade | Outperform | $25 → $28 |
| 29 July 2026 | Canaccord Genuity | Maintains | Buy | $30 → $36 |
| 29 July 2026 | Macquarie | Maintains | Outperform | $35 → $38 |
| 29 July 2026 | Needham | Maintains | Buy | $29 → $35 |
| 28 July 2026 | BTIG | Reiterates | Buy | $38 |
| 28 July 2026 | Needham | Reiterates | Buy | $29 |
| 25 June 2026 | BTIG | Maintains | Buy | — |
| 25 June 2026 | BTIG | Maintains | Buy | $33 → $38 |
| 16 June 2026 | Freedom Broker | Initiates | Hold | — |
| 27 May 2026 | B. Riley Securities | Maintains | Buy | — |
| 14 May 2026 | Jefferies | Maintains | Buy | — |
| 13 May 2026 | BTIG | Maintains | Buy | — |
| 7 May 2026 | Macquarie | Maintains | Outperform | — |
| 7 May 2026 | Needham | Maintains | Buy | — |
| 9 Apr 2026 | Cantor Fitzgerald | Maintains | Overweight | — |
| 4 Mar 2026 | Canaccord Genuity | Maintains | Buy | — |
| 4 Mar 2026 | Macquarie | Maintains | Outperform | — |
| 3 Mar 2026 | Cantor Fitzgerald | Maintains | Overweight | — |
| 3 Mar 2026 | HC Wainwright & Co. | Reiterates | Buy | — |
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Computed off the Friday close and sent before the US open.
Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. CORZ appears on the weeks it earns a place.
Both lines are total return — dividends reinvested — so the comparison is honest on both sides.
Over the twelve months to 9 Sept 2026, Core Scientific, Inc. returned +24.5% against +18.5% for the S&P 500, dividends included.
Download this chart as an image — free to reuse; link this page as the source.
Data provided by Twelve Data
Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.
A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.
Cheaper than 96% of US stocks
Cheaper than 12% of US stocks
Cheaper than 95% of US stocks
Cheaper than 96% of US stocks
Higher than 93% of US stocks
Higher than 85% of US stocks
Higher than 53% of US stocks
Higher than 59% of US stocks
Higher than 73% of US stocks
Higher than 88% of US stocks
Higher than 36% of US stocks
Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.
The headline figures, each with its date. Every row carries its own link — cite it straight from here.
Core Scientific, Inc. has a market value of $5.8B and an enterprise value of $8.7B.
Revenue in the twelve months to 30 June 2026: $440.3M. The latest quarter grew 108.8% year on year.
Net income over the same four quarters: −$1.4B, a −325.3% net margin.
Diluted earnings per share, trailing twelve months: $−4.42.
Free cash flow in the twelve months to 30 June 2026: −$957.8M.
Trailing P/E: −20.6×; forward P/E: 129.2× — the forward figure prices analyst consensus estimates, not reported earnings.
Core Scientific, Inc. employs 325 people — $1.4M of revenue per employee.
Data provided by Twelve Data
The nearest names by industry and size, scored by the same model — like for like.
Look up any of the roughly 4,600 stocks we score.
The rank is the raw material. Whether the rules would actually own Core Scientific, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →
A Core Scientific director purchased 7,000 shares in a transaction valued at $134,330. The purchase increased the director's direct equity holdings by 3%.
Why it matters — A director's personal purchase of company shares may signal confidence in Core Scientific's prospects, which CORZ watchers often monitor.
Core Scientific director Elizabeth Crain purchased 6,000 shares of the company, a transaction valued at approximately $110,000. The acquisition increased her direct equity holdings in Core Scientific by 9%.
Why it matters — A director increasing her stake in the company by 9% is notable for CORZ watchers as an insider transaction signal.
Core Scientific executive Todd Duchene sold 10,000 shares on August 31, 2026, at a weighted average price of $16.234 per share, for a total value of approximately $162,300. The transaction represented 0.52% of the stake held before the filing.
Why it matters — Insider share sales can be of interest to CORZ watchers as a signal of executive activity, though the small percentage sold suggests limited significance.
Rising long-term Treasury yields pressured the AI infrastructure trade on Tuesday morning, with pure-play buildout names—including Applied Digital, Cipher Mining, and Core Scientific—falling by 3% to 6%. The declines hit these capital-intensive names more than the broader data center category.
Why it matters — As a capital-hungry AI infrastructure pure-play, Core Scientific is exposed to moves in long-term Treasury yields, which investors are watching as a driver of its share price.
AI data center pure plays sold off together on Friday, with IREN Limited's fiscal 2026 impairment charge weighing on capex-heavy peers. The broad decline signals investors re-pricing the group's transition costs across the sector.
Why it matters — As a fellow AI data center player, CORZ could be affected by investor sentiment around the group's capital-heavy transition costs.
The 17 Wall Street analysts covering Core Scientific, Inc. have a median 12-month price target of $36, with estimates ranging from $28 to $55. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.
Of the 17 analysts covering Core Scientific, Inc., 16 rate it a Buy, 1 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks Core Scientific, Inc. 18 out of 100 across roughly 4,600 US stocks as at 8 Sept 2026. None of this is personal advice — it does not consider your circumstances.
As at 8 Sept 2026, Core Scientific, Inc. ranks 18 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Momentum (75 of 100).
No one can know that. What the data says: the median 12-month target from 17 analysts implies +99.0% from the last close, and Ticker Nerd's factor model ranks Core Scientific, Inc. 18 out of 100 as at 8 Sept 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.
No analyst covering Core Scientific, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for CORZ are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $28 to $55 over the next 12 months.
Core Scientific, Inc. returned +24.5% over the 12 months to 9 Sept 2026, with dividends reinvested. Past performance does not indicate future returns.
Core Scientific, Inc. is a digital infrastructure and data center company that designs, builds, and operates large-scale facilities for high-density colocation and computing workloads.
The most recent item we track (The Motley Fool, 8 Sept 2026): "Core Scientific Director Purchases 7,000 Shares". A Core Scientific director purchased 7,000 shares in a transaction valued at $134,330. The purchase increased the director's direct equity holdings by 3%.
Core Scientific, Inc. is a digital infrastructure and data center company that designs, builds, and operates large-scale facilities for high-density colocation and computing workloads. Core Scientific provides space, power, cooling, security, and facility operations for customers running artificial intelligence and other high-performance computing applications, while also offering blockchain infrastructure and digital asset mining services. Its business is organized around colocation, self-mining, and hosted mining activities, allowing it to serve both enterprise compute clients and digital asset customers. Core Scientific’s role in the market centers on supplying power-dense, purpose-built infrastructure that supports the growing demand for compute-intensive workloads and specialized digital asset operations.
CEO Mr. Adam Sullivan · 325 employees · United States · https://corescientific.com
